Related references
Note: Only part of the references are listed.Functional CDKN2A assay identifies frequent deleterious alleles misclassified as variants of uncertain significance
Hirokazu Kimura et al.
ELIFE (2022)
First international workshop of the ATM and cancer risk group (4-5 December 2019)
Fabienne Lesueur et al.
FAMILIAL CANCER (2022)
FRAMe: Familial Risk Assessment of Melanoma-a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanoma
Elizabeth A. Holland et al.
FAMILIAL CANCER (2021)
CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015-2020: implications for novel national recommendations
Maria Pissa et al.
ACTA ONCOLOGICA (2021)
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia
B. Dalmasso et al.
GENETICS IN MEDICINE (2021)
Clinical histopathological features and CDKN2A/ CDK4/MITF mutational status of patients with multiple primary melanomas from Bologna: Italy is a fascinating but complex mosaic
Emi Dika et al.
ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY (2021)
NEK11 as a candidate high-penetrance melanoma susceptibility gene
Eirini Christodoulou et al.
JOURNAL OF MEDICAL GENETICS (2020)
Evolution of approaches to identify melanoma missing heritability
Bruna Dalmasso et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2020)
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients
Giulia Ciccarese et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1
Lorenza Pastorino et al.
CANCERS (2020)
A Single Center Retrospective Review of Patients from Central Italy Tested for Melanoma Predisposition Genes
Paola De Simone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT
Nicholas J. Taylor et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study
Milena Casula et al.
BMC CANCER (2019)
CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe
Thomas P. Potjer et al.
JOURNAL OF MEDICAL GENETICS (2018)
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide
Sebastian Walpole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing
Mykyta Artomov et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy
Cristina Pellegrini et al.
MELANOMA RESEARCH (2017)
Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing
Mykyta Artomov et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Identification, genetic testing, and management of hereditary melanoma
Sancy A. Leachman et al.
CANCER AND METASTASIS REVIEWS (2017)
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup
William Bruno et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
POLE mutations in families predisposed to cutaneous melanoma
Lauren G. Aoude et al.
FAMILIAL CANCER (2015)
Nonsense Mutations in the Shelterin Complex Genes ACD and TERF2IP in Familial Melanoma
Lauren G. Aoude et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma
Jianxin Shi et al.
NATURE GENETICS (2014)
Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants
Hanne Eknes Puntervoll et al.
JOURNAL OF MEDICAL GENETICS (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
Corine Bertolotto et al.
NATURE (2011)
Contribution of susceptibility gene variants to melanoma risk in families from the Veneto region of Italy
Chiara Menin et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
Clinical genetic testing for familial melanoma in Italy: A cooperative study
William Bruno et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
Alisa M. Goldstein et al.
CANCER RESEARCH (2006)
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma
Paola Ghiorzo et al.
HUMAN MOLECULAR GENETICS (2006)
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients
M Mantelli et al.
MELANOMA RESEARCH (2004)
INK4/ARF germline alterations in pancreatic cancer patients
P Ghiorzo et al.
ANNALS OF ONCOLOGY (2004)
Share Paper
